Guardant Health, INC Form 4 insider transactions

Director Tariq Musa acquired 250 shares of Guardant Health via RSU vesting and sold 116 shares to cover tax obligations.

Chief Legal Officer John G. Saia acquired 7,569 shares of Guardant Health common stock through the vesting of restricted stock units.

Guardant Health Chief People Officer Terilyn J. Monroe reported a sale of 3,832 shares of common stock on April 6, 2026, for $92.68 per share.

Guardant Health's Chief Legal Officer, John G. Saia, reported transactions involving the acquisition of common stock and vesting of restricted stock units.

Guardant Health Chief People Officer Terilyn J. Monroe reported transactions involving restricted stock units and common stock.

Guardant Health, Inc. (GH) Chief Information Officer Kumud Kalia reported transactions involving restricted stock units and common stock.

Guardant Health, Inc. Chief Commercial Officer Chris Freeman reported transactions involving restricted stock units and common stock.

Guardant Health's Chief Medical Officer, Craig Eagle, reported on April 1, 2026, regarding the vesting of restricted stock units and associated tax withholding.

Darya Chudova, Chief Technology Officer at Guardant Health, Inc., reported transactions involving the acquisition of common stock and restricted stock units.

Guardant Health CFO Michael Brian Bell reported transactions involving restricted stock units and common stock, including shares retained for tax withholding.

Guardant Health, Inc. executive AmirAli Talasaz reported transactions involving common stock and restricted stock units, including acquisitions and dispositions related to vesting and tax withholding.

Guardant Health Co-CEO Helmy Eltoukhy reported transactions involving the acquisition of company stock, including shares from vested Restricted Stock Units and shares retained for tax withholding.

Guardant Health Director Steve E. Krognes reported the acquisition of 155 shares of common stock through the vesting of restricted stock units.

Guardant Health Director Roberto Mignone reported the acquisition of 264 shares of common stock through the vesting of restricted stock units.

Guardant Health Director Musa Tariq sold 348 shares of common stock at $88.09 per share under a pre-arranged trading plan.

Guardant Health Director Manuel Hidalgo Medina converted 232 restricted stock units into common stock on March 17, 2026.

Guardant Health's Co-Chief Executive Officer, AmirAli Talasaz, reported multiple transactions involving common stock and restricted stock units, including vesting and tax-related dispositions.

Guardant Health's Co-Chief Executive Officer, Helmy Eltoukhy, filed a Form 4 detailing planned equity transactions, including RSU vestings and new grants, scheduled for 2026.

Guardant Health Director Tariq Musa converted 249 restricted stock units into common stock on March 15, 2026, as part of a pre-scheduled vesting.

Guardant Health's Chief Legal Officer, John G. Saia, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations.

Guardant Health's Chief Information Officer, Kumud Kalia, reported the vesting of performance-based and standard restricted stock units, alongside a tax-related share disposition.

Guardant Health's Chief Commercial Officer, Chris Freeman, vested a significant number of restricted stock units, acquiring common stock and selling a portion to cover tax obligations.

Guardant Health's Chief Medical Officer, Craig Eagle, reported the vesting of performance-based and time-based restricted stock units, alongside shares withheld for tax obligations.

Guardant Health's Chief Technology Officer, Darya Chudova, reported the vesting of performance-based restricted stock units and the subsequent disposition of shares for tax withholding.

Guardant Health's CFO, Michael Brian Bell, reported the acquisition of common stock through RSU vesting and subsequent sales, adjusting his beneficial ownership.

Guardant Health's Chief Legal Officer, John G. Saia, was granted 20,448 restricted stock units vesting over three years.

Guardant Health, Inc. has granted 17,040 restricted stock units to Chief People Officer Terilyn J. Monroe, vesting over three years.

Guardant Health's Chief Information Officer, Kumud Kalia, received a grant of 13,632 Restricted Stock Units with a three-year vesting schedule.

Guardant Health's Chief Commercial Officer, Chris Freeman, received a grant of 18,744 restricted stock units, aligning executive incentives with future company performance.

Guardant Health's Chief Technology Officer, Darya Chudova, was granted 23,856 Restricted Stock Units with a three-year vesting schedule.